Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
- PMID: 19563516
- PMCID: PMC2757454
- DOI: 10.1111/j.1601-183X.2009.00504.x
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
Abstract
N-methyl-D-aspartate receptors (NMDARs) play a pivotal role in excitatory neurotransmission, synaptic plasticity and brain development. Clinical and experimental evidence suggests a dysregulation of NMDAR function and glutamatergic pathways in the pathophysiology of schizophrenia. We evaluated electrophysiological and behavioral properties of NMDAR deficiency utilizing mice that express only 5-10% of the normal level of NMDAR NR1 subunit. Auditory and visual event related potentials yielded significantly increased amplitudes for the P20 and N40 components in NMDAR deficient (NR1(neo)-/-) mice suggesting decreased inhibitory tone. Compared to wild types, NR1(neo)-/- mice spent less time in social interactions and showed reduced nest building. NR1(neo)-/- mice displayed a preference for open arms of a zero maze and central zone of an open field, possibly reflecting decreased anxiety-related behavioral inhibition. However, locomotor activity did not differ between groups in either home cage environment or during behavioral testing. NR1(neo)-/- mice displayed hyperactivity only when placed in a large unfamiliar environment, suggesting that neither increased anxiety nor non-specific motor activation accounts for differential behavioral patterns. Data suggest that NMDAR NR1 deficiency causes disinhibition in sensory processing as well as reduced behavioral inhibition and impaired social interactions. The behavioral signature in NR1(neo)-/- mice supports the impact of impaired NMDAR function in a mouse model with possible relevance to negative symptoms in schizophrenia.
Figures








Similar articles
-
Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.J Pharmacol Exp Ther. 2009 Oct;331(1):308-18. doi: 10.1124/jpet.109.150938. Epub 2009 Jul 14. J Pharmacol Exp Ther. 2009. PMID: 19602553 Free PMC article.
-
Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?Genes Brain Behav. 2012 Aug;11(6):740-50. doi: 10.1111/j.1601-183X.2012.00816.x. Genes Brain Behav. 2012. PMID: 22726567 Free PMC article.
-
NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.Prog Brain Res. 2009;179:51-8. doi: 10.1016/S0079-6123(09)17906-2. Epub 2009 Nov 20. Prog Brain Res. 2009. PMID: 20302817 Review.
-
Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.Brain Res. 2010 Jan 11;1307:166-76. doi: 10.1016/j.brainres.2009.10.023. Epub 2009 Oct 22. Brain Res. 2010. PMID: 19840778 Free PMC article.
-
The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.Acta Biochim Biophys Sin (Shanghai). 2016 Mar;48(3):209-19. doi: 10.1093/abbs/gmv135. Epub 2016 Feb 1. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26837414 Free PMC article. Review.
Cited by
-
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.Mol Psychiatry. 2013 Nov;18(11):1185-92. doi: 10.1038/mp.2012.137. Epub 2012 Oct 16. Mol Psychiatry. 2013. PMID: 23070074 Free PMC article.
-
Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.Schizophr Bull. 2010 Mar;36(2):271-88. doi: 10.1093/schbul/sbp125. Epub 2009 Nov 24. Schizophr Bull. 2010. PMID: 19934211 Free PMC article.
-
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.Neuropsychopharmacology. 2011 Jun;36(7):1489-504. doi: 10.1038/npp.2011.34. Epub 2011 Mar 23. Neuropsychopharmacology. 2011. PMID: 21430651 Free PMC article.
-
Resting-state EEG and MEG gamma frequencies in schizophrenia: a systematic review and exploratory power-spectrum metanalysis.Schizophrenia (Heidelb). 2025 Mar 21;11(1):48. doi: 10.1038/s41537-025-00596-z. Schizophrenia (Heidelb). 2025. PMID: 40128239 Free PMC article. Review.
-
Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.Neuropsychopharmacology. 2010 Jun;35(7):1477-84. doi: 10.1038/npp.2010.17. Epub 2010 Mar 3. Neuropsychopharmacology. 2010. PMID: 20200507 Free PMC article.
References
-
- Ballard TM, Pauly-Evers M, Higgins GA, Ouagazzal AM, Mutel V, Borroni E, Kemp JA, Bluethmann H, Kew JN. Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity. J Neurosci. 2002;22:6713–6723. - PMC - PubMed
-
- Bickel S, Lipp HP, Umbricht D. Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function. Neuropsychopharmacology. 2008;33:1680–1689. - PubMed
-
- Brodkin ES. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behavioural brain research. 2007;176:53–65. - PubMed
-
- Brodkin ES, Hagemann A, Nemetski SM, Silver LM. Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain research. 2004;1002:151–157. - PubMed
-
- Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, Siegel SJ. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res. 2004;29:1179–1188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases